Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Please refer attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition Ltd has informed BSE that its Board of Directors will meet on Wednesday, February 11, 2026, at Mumbai. The key agenda is to consider and approve the unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26). The company has also notified that the trading window for its equity shares will remain closed until February 13, 2026, in line with insider trading regulations. This is a routine regulatory filing under SEBI LODR Regulation 29(1)(a).
No immediate impact on shareholders — this is a standard advance notice ahead of the Q3 results announcement. Investors should watch the actual results on or after February 11, 2026 for any meaningful updates on revenue, profits, or business outlook.